| ESRRA |
ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
0.265 |
Evidence |
|
| VDR |
VDR, NR1I1: Vitamin D3 receptor |
RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
0.265 |
Evidence |
O
|
| ERG |
ERG: Transcriptional regulator ERG |
APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
0.265 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
ADIPOQ |
ADIPOQ, ACDC, ACRP30, APM1, GBP28: Adiponectin precursor |
0.265 |
Evidence |
|
| HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
0.265 |
Evidence |
|
| CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
CD69 |
CD69: Early activation antigen CD69 |
0.265 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
0.265 |
Evidence |
|
| C7 |
C7: Complement component C7 precursor |
LUM |
LUM, LDC: Lumican precursor |
0.265 |
Evidence |
|
| C7 |
C7: Complement component C7 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
0.265 |
Evidence |
|
| C7 |
C7: Complement component C7 precursor |
TNXB |
TNXB, HXBL, TNX, TNXB1, TNXB2, XB: Tenascin-X precursor |
0.265 |
Evidence |
|
| TXN |
TXN, TRDX, TRX, TRX1: Thioredoxin |
COL17A1 |
COL17A1, BP180, BPAG2: Collagen alpha-1(XVII) chain |
0.265 |
Evidence |
|
| TXN |
TXN, TRDX, TRX, TRX1: Thioredoxin |
FKBP10 |
FKBP10, FKBP65, PSEC0056: FK506-binding protein 10 precursor |
0.265 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CSPG2 |
IPI00009802 |
0.265 |
Evidence |
|
| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
0.265 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
BAZ1B |
BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain |
0.265 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
0.265 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
BRD3 |
BRD3, KIAA0043, RING3L: Bromodomain-containing protein 3 |
0.265 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
0.265 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
MYBL2 |
MYBL2, BMYB: Myb-related protein B |
0.265 |
Evidence |
|
| FURIN |
FURIN, FUR, PACE, PCSK3: Furin precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
HSPG2 |
HSPG2: Basement membrane-specific heparan sulfate proteoglycan core protein prec |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
MFAP4 |
MFAP4: Microfibril-associated glycoprotein 4 precursor |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
TNC |
TNC, HXB: Tenascin precursor |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
CPM |
CPM: Carboxypeptidase M precursor |
0.265 |
Evidence |
|